Exhibit 107
Calculation of Filing Fees Table
Form S-8
(Form Type)
Acasti Pharma Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type |
Security Class Title |
Fee Calculation Rule |
Amount Registered |
Proposed Maximum Offering Price Per Unit (2) |
Maximum Aggregate Offering Price |
Fee Rate |
Amount of Registration Fee |
Equity |
Common Shares, no par value per share |
Rule 457(c) and Rule 457(h) |
1,483,140 |
$2.07 |
$3,070,099.80 |
$110.20 per million |
$338.32 |
Total Offering Amounts |
|
|
$3,070,099.80 |
|
$338.32 |
||
Total Fee Offsets |
|
|
|
|
$0 |
||
Net Fee Due |
|
|
|
|
$338.32 |
||
(1) Represents 1,483,140 common shares reserved for issuance under the Acasti Pharma Inc. Stock Option Plan, as amended, and the Acasti Pharma Inc. Equity Incentive Plan, as amended (together the “Plans”). Pursuant to Rule 416 of the Securities Act of 1933, as amended (the “Securities Act”) there are also registered hereunder such indeterminate number of additional shares as may become available for issuance pursuant to the Plans as a result of the antidilution provisions contained therein, including stock splits and other similar transactions.
(2) Estimated in accordance with paragraphs (c) and (h) of Rule 457 of the Securities Act, based upon the average of the daily high and low prices of shares of the registrant’s common stock on August 24, 2023, as reported on the Nasdaq Capital Market.
MACROBUTTON DocID \\4138-5887-4185 v1